PHV-wordings
Here you will find safety-relevant information that must be implemented in the corresponding product information due to a PHV issues.
Due to the relaunch of the EMA website in December 2023, you will find the current links to the entries prior to December 01, 2023 at https://www.ema.europa.eu
Search narrowed by
Ropinirol
PSUR-outcome
|
20/05/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Brivudine
PSUR-outcome
|
19/05/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Aripiprazole
PSUR-outcome
|
19/05/2020
Further information can be found in the Commission Decision and its annexes, which are available in all EU languages on the European Commission's (EC) website.
Ibuprofen/Pseudoephedrine
PSUR-outcome
|
08/04/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Pitavastatin
PSUR-outcome
|
08/04/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Pholcodine
PSUR-outcome
|
06/04/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Iobitridol
PSUR-outcome
|
06/04/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Methadone
PSUR-outcome
|
24/03/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Levomethadone
PSUR-outcome
|
13/03/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
Sulfametrole / Trimethoprim, Sulfadiazine / Trimethoprim, Sulfamethoxazole / Trimethoprim (Co-trimoxazole)
PSUR-outcome
|
11/03/2020
Further information and amendments to the product information in all EU languages can be found on the EMA website.
